Gendoo

MeSH keywords -> Related genes, diseases (OMIM)


Query MeSH keywords list

01 Genetics, Population [NCBI]

Gene


 Gene Link Information
Gain		 01



OMIM


 OMIM Link Information
gain		 01
tongue, pigmented fungiform papillae of [NCBI] 0.00246671
cataract, congenital or juvenile [NCBI] 0.00170238
IBD2 [NCBI] 0.00116068
IBD5 [NCBI] 0.00107662
Sf [NCBI] 0.00103063
alzheimer disease 10 [NCBI] 0.00103063
IBD4 [NCBI] 0.000766277
hypertension, essential, susceptibility to, 2 [NCBI] 0.000766277
MAFD4 [NCBI] 0.000766277
MAFD1 [NCBI] 0.000711533
diabetes mellitus, insulin-dependent, 2 [NCBI] 0.000710319
CHDS8 [NCBI] 0.000667037
IBD6 [NCBI] 0.000667037
musk, inability to smell [NCBI] 0.000667037
gout susceptibility 1 [NCBI] 0.000602894
CELIAC6 [NCBI] 0.000602894
stature as a quantitative trait [NCBI] 0.000517763
ECA1 [NCBI] 0.000486593
mental health wellness 1 [NCBI] 0.000486593
strabismus, susceptibility to [NCBI] 0.000460034
achoo syndrome [NCBI] 0.000460034
ADFN [NCBI] 0.000436923
spatial visualization, aptitude for [NCBI] 0.000416487
mesothelioma, malignant [NCBI] 0.000366544
lactase persistence [NCBI] 0.000364168
leber optic atrophy, susceptibility to [NCBI] 0.000352679
apnea, obstructive sleep [NCBI] 0.000340678
PAND1 [NCBI] 0.000339869
ESD [NCBI] 0.000236153
VLDLRCH [NCBI] 0.000230608
GC [NCBI] 0.000223611
holoprosencephaly [NCBI] 0.000222698
RA [NCBI] 0.000217202
PCD [NCBI] 0.000216968
LGMD2H [NCBI] 0.000210377
SLE [NCBI] 0.000200044
behcet syndrome [NCBI] 0.000186755
G6PD [NCBI] 0.000177715
orofacial cleft 5 [NCBI] 0.000174491
novelty seeking personality trait [NCBI] 0.000162685
TF [NCBI] 0.000155819
CF [NCBI] 0.000150665
phenylketonuria [NCBI] 0.000131112
hypercholesterolemia, autosomal dominant [NCBI] 0.000126876
MTCO2 [NCBI] 0.00012666
gracile syndrome [NCBI] 0.000125998
acheiropody [NCBI] 0.000122232
obesity [NCBI] 0.000121836
carabelli anomaly of maxillary molar teeth [NCBI] 0.000114912
SGCG [NCBI] 0.000106385
MJD [NCBI] 0.000106018
autism [NCBI] 0.000104248
MCM6 [NCBI] 0.000103851
IBD1 [NCBI] 0.000101173
ulcerative colitis, susceptibility to [NCBI] 9.69257e-05
fragile x mental retardation syndrome [NCBI] 9.53823e-05
EGF [NCBI] 9.38245e-05
HBB [NCBI] 9.35613e-05
HP [NCBI] 9.04643e-05
DFNB1 [NCBI] 8.86846e-05
xh antigen [NCBI] 8.72027e-05
alkaline phosphatase, blood group-associated [NCBI] 8.72027e-05
IL23R [NCBI] 8.34878e-05
ADH2 [NCBI] 8.11542e-05
FRDA [NCBI] 7.86096e-05
DRD4 [NCBI] 7.84337e-05
APOE [NCBI] 7.81688e-05
CELIAC3 [NCBI] 7.67843e-05
egasyn [NCBI] 7.67843e-05
earlobe attachment: attached vs unattached [NCBI] 7.67843e-05
isovaleric acid, inability to smell [NCBI] 7.67843e-05
mandibulofacial dysostosis, treacher collins type, autosomal recessive [NCBI] 7.67843e-05
YT [NCBI] 7.67843e-05
pulmonary hypertension, familial persistent, of the newborn [NCBI] 7.67843e-05
pyruvate kinase deficiency of red cells [NCBI] 7.23194e-05
ZFY [NCBI] 7.0215e-05
clubfoot [NCBI] 7.00412e-05
varicose veins [NCBI] 7.00412e-05
australia antigen [NCBI] 7.00412e-05
FIDD [NCBI] 7.00412e-05
lactase deficiency, congenital [NCBI] 7.00412e-05
ALB [NCBI] 6.91327e-05
TCF7L2 [NCBI] 6.72842e-05
GPI [NCBI] 6.57102e-05
ODG1 [NCBI] 6.50437e-05
AH [NCBI] 6.50437e-05
cd4/cd8 t-cell ratio [NCBI] 6.50437e-05
fragile site 10q25 [NCBI] 6.50437e-05
respiratory distress syndrome in premature infants [NCBI] 6.50437e-05
MAFD6 [NCBI] 6.49472e-05
gastroschisis [NCBI] 6.10743e-05
sarcosinemia [NCBI] 6.10743e-05
peroxidase and phospholipid deficiency in eosinophils [NCBI] 6.10743e-05
PLG [NCBI] 6.04209e-05
FSHMD1A [NCBI] 5.94932e-05
SHEP3 [NCBI] 5.77842e-05
endometrial cancer [NCBI] 5.77842e-05
mental health wellness 2 [NCBI] 5.77842e-05
HMS [NCBI] 5.77842e-05
LSFC [NCBI] 5.77842e-05
TNF [NCBI] 5.67598e-05
ear wax, wet/dry [NCBI] 5.49769e-05
hypertension, essential [NCBI] 5.33878e-05
asthma, susceptibility to [NCBI] 5.33878e-05
tobacco addiction, susceptibility to [NCBI] 5.25307e-05
AK1 [NCBI] 5.24113e-05
HLA-A [NCBI] 5.23013e-05
IGHA2 [NCBI] 5.18996e-05
hyperornithinemia-hyperammonemia-homocitrullinuria syndrome [NCBI] 5.03647e-05
17-@beta hydroxysteroid dehydrogenase iii deficiency [NCBI] 5.03647e-05
PSORS1 [NCBI] 4.93833e-05
TSD [NCBI] 4.88048e-05
NOD2 [NCBI] 4.84595e-05
PKLR [NCBI] 4.84595e-05
galactokinase deficiency [NCBI] 4.84225e-05
MC1R [NCBI] 4.83741e-05
severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-negative, nk cell-negative, due to adenosine deaminase deficiency [NCBI] 4.8005e-05
MTC [NCBI] 4.66633e-05
sarcoidosis [NCBI] 4.66633e-05
SACS [NCBI] 4.66633e-05
tight skin contracture syndrome, lethal [NCBI] 4.66633e-05
ACTN3 [NCBI] 4.62918e-05
NOTCH4 [NCBI] 4.62918e-05
SHEP1 [NCBI] 4.50565e-05
synovitis, granulomatous, with uveitis and cranial neuropathies [NCBI] 4.50565e-05
indifference to pain, congenital, autosomal recessive [NCBI] 4.50565e-05
parkinson disease, mitochondrial [NCBI] 4.50565e-05
MDH1 [NCBI] 4.3648e-05
PEPC [NCBI] 4.3648e-05
SORD [NCBI] 4.3648e-05
sitosterolemia [NCBI] 4.35785e-05
amyotrophic lateral sclerosis-parkinsonism/dementia complex 1 [NCBI] 4.35785e-05
USH1C [NCBI] 4.35785e-05
ADH3 [NCBI] 4.25217e-05
FFI [NCBI] 4.22924e-05
vitamin d-dependent rickets, type i [NCBI] 4.22109e-05
MCPH1 [NCBI] 4.22109e-05
JH [NCBI] 4.22109e-05
ADA [NCBI] 4.17103e-05
KIR3DL1 [NCBI] 4.1495e-05
severe combined immunodeficiency with sensitivity to ionizing radiation [NCBI] 4.0939e-05
pseudoxanthoma elasticum, forme fruste [NCBI] 4.0939e-05
ADH1 [NCBI] 4.05518e-05
dopamine beta-hydroxylase deficiency, congenital [NCBI] 3.97506e-05
NPHS1 [NCBI] 3.97506e-05
blood group, p system [NCBI] 3.97506e-05
pituitary dwarfism iii [NCBI] 3.97506e-05
SCZD [NCBI] 3.94669e-05
TMEM183B [NCBI] 3.72815e-05
PRL [NCBI] 3.68133e-05
IL6R [NCBI] 3.67304e-05
CBP [NCBI] 3.67304e-05
severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-negative, nk cell-positive [NCBI] 3.65969e-05
CFTR [NCBI] 3.60675e-05
GLC3A [NCBI] 3.56594e-05
CCAL2 [NCBI] 3.56594e-05
histidinemia [NCBI] 3.56594e-05
HSAN1 [NCBI] 3.56594e-05
PGD [NCBI] 3.54981e-05
LDLR [NCBI] 3.52457e-05
ORM1 [NCBI] 3.49284e-05
LCT [NCBI] 3.48007e-05
BBS [NCBI] 3.45511e-05
CRC [NCBI] 3.45123e-05
myasthenic syndrome, congenital, associated with acetylcholine receptor deficiency [NCBI] 3.39234e-05
diastrophic dysplasia [NCBI] 3.39234e-05
methylmalonic aciduria due to methylmalonyl-coa mutase deficiency [NCBI] 3.39234e-05
CA1 [NCBI] 3.38677e-05
MSX1 [NCBI] 3.33723e-05
MDD [NCBI] 3.33314e-05
alcohol dependence [NCBI] 3.31167e-05
CPX [NCBI] 3.23464e-05
ATXN8OS [NCBI] 3.20039e-05
osteoarthritis [NCBI] 3.16094e-05
HSCR1 [NCBI] 3.13804e-05
EVC [NCBI] 3.09034e-05
MAOA [NCBI] 3.04495e-05
musical perfect pitch [NCBI] 3.02259e-05
TPMT [NCBI] 2.91887e-05
CBD [NCBI] 2.90051e-05
graves disease [NCBI] 2.89485e-05
IDDM [NCBI] 2.86463e-05
LGMD2C [NCBI] 2.83453e-05
AGTR1 [NCBI] 2.74722e-05
mitochondrial complex iv deficiency [NCBI] 2.72021e-05
PGL1 [NCBI] 2.72021e-05
DRPLA [NCBI] 2.68529e-05
AIS [NCBI] 2.66476e-05
CTLA4 [NCBI] 2.66454e-05
OCA2 [NCBI] 2.61349e-05
drug metabolism, poor, cyp2d6-related [NCBI] 2.61349e-05
ADH6 [NCBI] 2.59434e-05
FCRL3 [NCBI] 2.59434e-05
IGHG4 [NCBI] 2.59434e-05
OTOG [NCBI] 2.59434e-05
C4A [NCBI] 2.58766e-05
malaria, susceptibility to [NCBI] 2.56271e-05
COH1 [NCBI] 2.51352e-05
PDS [NCBI] 2.46583e-05
CTNS [NCBI] 2.46583e-05
mucolipidosis ii [NCBI] 2.46583e-05
homocystinuria due to deficiency of n(5,10)-methylenetetrahydrofolate reductase activity [NCBI] 2.46583e-05
MG [NCBI] 2.40676e-05
AGT [NCBI] 2.40586e-05
ZNF202 [NCBI] 2.39331e-05
neutrophil-specific antigen 1 [NCBI] 2.39331e-05
PAXIP1 [NCBI] 2.39331e-05
UTY [NCBI] 2.39331e-05
CTDP1 [NCBI] 2.39331e-05
PGM1 [NCBI] 2.34491e-05
CDSP [NCBI] 2.33104e-05
F2 [NCBI] 2.32534e-05
HSAN3 [NCBI] 2.28864e-05
SLC11A1 [NCBI] 2.26871e-05
porphyria, acute intermittent [NCBI] 2.2474e-05
ADAM33 [NCBI] 2.24412e-05
ATG16L1 [NCBI] 2.24412e-05
ADH7 [NCBI] 2.24412e-05
ZAN [NCBI] 2.24412e-05
GPR44 [NCBI] 2.24412e-05
EVC [NCBI] 2.24412e-05
CDKAL1 [NCBI] 2.24412e-05
PTPN2 [NCBI] 2.24412e-05
TH [NCBI] 2.22073e-05
HFE [NCBI] 2.21557e-05
DYT1 [NCBI] 2.16821e-05
sotos syndrome [NCBI] 2.16821e-05
GPT [NCBI] 2.14733e-05
thyroid carcinoma, papillary [NCBI] 2.13015e-05
CLEC16A [NCBI] 2.12545e-05
CHRNB4 [NCBI] 2.12545e-05
SH2B3 [NCBI] 2.12545e-05
KIR2DL2 [NCBI] 2.12545e-05
FUCA2 [NCBI] 2.12545e-05
CALU [NCBI] 2.12545e-05
CCR5 [NCBI] 2.09934e-05
CD [NCBI] 2.06428e-05
galactosemia [NCBI] 2.0569e-05
SLC4A1 [NCBI] 2.03863e-05
PRNP [NCBI] 2.02975e-05
IGF2BP2 [NCBI] 2.02696e-05
MDH2 [NCBI] 2.02696e-05
RENBP [NCBI] 2.02696e-05
DBY [NCBI] 2.02696e-05
ADH4 [NCBI] 2.02696e-05
HHT [NCBI] 2.02163e-05
sickle cell anemia [NCBI] 2.02163e-05
HNPP [NCBI] 2.02163e-05
AN2 [NCBI] 1.98721e-05
maple syrup urine disease [NCBI] 1.98721e-05
HD [NCBI] 1.97284e-05
IRGM [NCBI] 1.94281e-05
AGRP [NCBI] 1.94281e-05
cocaine- and amphetamine-regulated transcript [NCBI] 1.94281e-05
USP9Y [NCBI] 1.94281e-05
ARPKD [NCBI] 1.92079e-05
MTHFR [NCBI] 1.91392e-05
PGAM1 [NCBI] 1.86937e-05
ABCG8 [NCBI] 1.86937e-05
hemojuvelin [NCBI] 1.86937e-05
complement component c1r deficiency [NCBI] 1.86937e-05
CASP10 [NCBI] 1.86937e-05
GBA [NCBI] 1.82657e-05
HEXA [NCBI] 1.81469e-05
IGHE [NCBI] 1.80426e-05
ZIC2 [NCBI] 1.80426e-05
A4GALT [NCBI] 1.80426e-05
IGKV [NCBI] 1.80426e-05
ERBB3 [NCBI] 1.80426e-05
LQT1 [NCBI] 1.7675e-05
INSIG2 [NCBI] 1.7458e-05
ACE [NCBI] 1.71157e-05
ORM2 [NCBI] 1.69277e-05
SPTLC1 [NCBI] 1.69277e-05
prostate cancer [NCBI] 1.68325e-05
HBA1 [NCBI] 1.65526e-05
F13B [NCBI] 1.64426e-05
CD209 [NCBI] 1.64426e-05
NDRG1 [NCBI] 1.64426e-05
BDNF [NCBI] 1.63516e-05
dystrophia myotonica 1 [NCBI] 1.6336e-05
MYOC [NCBI] 1.6321e-05
ornithine transcarbamylase deficiency, hyperammonemia due to [NCBI] 1.60411e-05
MEN2A [NCBI] 1.60411e-05
HLA-C [NCBI] 1.59958e-05
SFTPC [NCBI] 1.59958e-05
DRD1 [NCBI] 1.59958e-05
SLC22A1 [NCBI] 1.55818e-05
CLEC4M [NCBI] 1.55818e-05
AGXT [NCBI] 1.55818e-05
GGH [NCBI] 1.55818e-05
PRH1 [NCBI] 1.55818e-05
PPARG [NCBI] 1.53893e-05
CMT1A [NCBI] 1.52959e-05
ME2 [NCBI] 1.51962e-05
JARID1D [NCBI] 1.51962e-05
GGCX [NCBI] 1.51962e-05
C4BPA [NCBI] 1.51962e-05
CPS1 [NCBI] 1.48354e-05
SCN9A [NCBI] 1.48354e-05
SLC22A8 [NCBI] 1.44965e-05
GABRG2 [NCBI] 1.44965e-05
SLC45A2 [NCBI] 1.44965e-05
GNB3 [NCBI] 1.44965e-05
BHMT [NCBI] 1.41771e-05
HBZ [NCBI] 1.41771e-05
ALDOA [NCBI] 1.41771e-05
CP [NCBI] 1.41629e-05
BRCA2 [NCBI] 1.39921e-05
IRDN [NCBI] 1.38751e-05
PGM3 [NCBI] 1.38751e-05
PTPN22 [NCBI] 1.38751e-05
breast cancer [NCBI] 1.37147e-05
GALK1 [NCBI] 1.35888e-05
CA2 [NCBI] 1.35888e-05
CTSD [NCBI] 1.33167e-05
ALPP [NCBI] 1.33167e-05
CR1 [NCBI] 1.33167e-05
SLC2A1 [NCBI] 1.33167e-05
DRD3 [NCBI] 1.33167e-05
SMA1 [NCBI] 1.32989e-05
LRE1 [NCBI] 1.30575e-05
AMPD1 [NCBI] 1.30575e-05
ASIP [NCBI] 1.30575e-05
complement component 8 deficiency, type i [NCBI] 1.30575e-05
CAPN10 [NCBI] 1.28101e-05
TCOF1 [NCBI] 1.28101e-05
SDHD [NCBI] 1.28101e-05
GATA3 [NCBI] 1.28101e-05
GJB3 [NCBI] 1.28101e-05
CYP1B1 [NCBI] 1.28101e-05
IRF1 [NCBI] 1.25734e-05
HLA-DRB1 [NCBI] 1.23466e-05
LRP5 [NCBI] 1.23466e-05
wilson disease [NCBI] 1.21354e-05
PGP [NCBI] 1.21291e-05
HTR2A [NCBI] 1.21291e-05
MPO [NCBI] 1.19602e-05
FMF [NCBI] 1.1926e-05
ALDH1A1 [NCBI] 1.192e-05
GSTM1 [NCBI] 1.192e-05
CD4 [NCBI] 1.192e-05
CHRNE [NCBI] 1.17187e-05
KL [NCBI] 1.17187e-05
DPYD [NCBI] 1.11571e-05
ADH5 [NCBI] 1.11571e-05
complement component 6 deficiency [NCBI] 1.11571e-05
APOH [NCBI] 1.11571e-05
AFP [NCBI] 1.10239e-05
GLI3 [NCBI] 1.09825e-05
HEMB [NCBI] 1.08835e-05
MN [NCBI] 1.08135e-05
oca2 gene [NCBI] 1.08135e-05
IL12B [NCBI] 1.08135e-05
HLA-B [NCBI] 1.08135e-05
SAA1 [NCBI] 1.06498e-05
POU1F1 [NCBI] 1.06498e-05
RARA [NCBI] 1.04911e-05
CYP2A6 [NCBI] 1.03371e-05
GHRL [NCBI] 1.03371e-05
WT1 [NCBI] 1.02813e-05
ABCC6 [NCBI] 1.01876e-05
ACP1 [NCBI] 1.01876e-05
ALDH2 [NCBI] 1.00423e-05
ACADS [NCBI] 1.00423e-05
CHEK2 [NCBI] 9.90101e-06
OPTN [NCBI] 9.90101e-06
RHCE [NCBI] 9.76356e-06
ATP7B [NCBI] 9.62973e-06
FY [NCBI] 9.62973e-06
protoporphyria, erythropoietic [NCBI] 9.49936e-06
PDHA1 [NCBI] 9.49936e-06
TCRG [NCBI] 9.37229e-06
ADHD [NCBI] 9.25752e-06
OPMD [NCBI] 9.25752e-06
factor x deficiency [NCBI] 8.78145e-06
methemoglobinemia due to deficiency of methemoglobin reductase [NCBI] 8.78145e-06
MTAP [NCBI] 8.45826e-06
isoniazid inactivation [NCBI] 8.35514e-06
CFB [NCBI] 8.25418e-06
GALT [NCBI] 8.1553e-06
C3 [NCBI] 7.87039e-06
SMS [NCBI] 7.84867e-06
DCC [NCBI] 7.77911e-06
REN [NCBI] 7.77911e-06
NPY [NCBI] 7.74859e-06
HBD [NCBI] 7.60171e-06
KCNQ1 [NCBI] 7.51547e-06
GRB2 [NCBI] 7.266e-06
SOD1 [NCBI] 7.11839e-06
PI [NCBI] 6.66016e-06
APOB [NCBI] 6.58209e-06
PCD [NCBI] 6.54233e-06
LRRK2 [NCBI] 6.45345e-06
PAX6 [NCBI] 6.38646e-06
RP [NCBI] 6.36823e-06
CJD [NCBI] 6.32325e-06
MLH1 [NCBI] 6.3205e-06
HBG1 [NCBI] 6.25552e-06
MTTL1 [NCBI] 6.12844e-06
TSHR [NCBI] 6.12844e-06
BCHE [NCBI] 6.09759e-06
IDUA [NCBI] 6.06629e-06
factor v deficiency [NCBI] 5.94465e-06
AD [NCBI] 5.62366e-06
COL2A1 [NCBI] 5.38469e-06
GCK [NCBI] 5.28137e-06
homocystinuria [NCBI] 5.2307e-06
AIRE [NCBI] 4.98666e-06
PTGS2 [NCBI] 4.98666e-06
PXE [NCBI] 4.86205e-06
TYR [NCBI] 4.84727e-06
SRY [NCBI] 4.84727e-06
CPB2 [NCBI] 4.66899e-06
NRG1 [NCBI] 4.54063e-06
ABCC8 [NCBI] 4.25749e-06
COL1A1 [NCBI] 4.25749e-06
ATM [NCBI] 4.10519e-06
PKD1 [NCBI] 4.06812e-06
MAPT [NCBI] 3.95924e-06
CCND1 [NCBI] 3.92369e-06
HBA2 [NCBI] 3.75135e-06
RET [NCBI] 3.68483e-06
HMBS [NCBI] 3.16887e-06
DMD [NCBI] 2.67349e-06
leber optic atrophy [NCBI] 2.52834e-06
FTD [NCBI] 2.28065e-06
TLR4 [NCBI] 2.08113e-06
CPI [NCBI] 1.96256e-06
DCK [NCBI] 1.94801e-06
FMR1 [NCBI] 1.68493e-06
BRCA1 [NCBI] 1.48019e-06
TYMS [NCBI] 1.45057e-06
APRT [NCBI] 1.28395e-06
SHBG [NCBI] 1.16982e-06
MBP [NCBI] 1.12801e-06
NF1 [NCBI] 1.06553e-06
LPL [NCBI] 1.04268e-06
TS [NCBI] 1.03817e-06
COMT [NCBI] 9.77736e-07
PD [NCBI] 9.66756e-07
TP53 [NCBI] 9.52784e-07
AR [NCBI] 6.82804e-07
SLC6A3 [NCBI] 5.47675e-07
MBL2 [NCBI] 5.25961e-07
SLC6A4 [NCBI] 5.19513e-07
CNTF [NCBI] 4.34946e-07
GAPDH [NCBI] 3.20407e-07
XDH [NCBI] 3.06679e-07
VDR [NCBI] 1.83971e-07
APC [NCBI] 6.62092e-08
hla-d histocompatibility type [NCBI] 2.63696e-08
lymphoma, non-hodgkin, familial [NCBI] 1.66618e-08
temporal arteritis [NCBI] 1.63007e-09
GTS [NCBI] 9.10227e-10



Database Center for Life Science